MX2009006635A - Compuestos de imidazolidinonil aminopirimidina para el tratamiento de cancer. - Google Patents

Compuestos de imidazolidinonil aminopirimidina para el tratamiento de cancer.

Info

Publication number
MX2009006635A
MX2009006635A MX2009006635A MX2009006635A MX2009006635A MX 2009006635 A MX2009006635 A MX 2009006635A MX 2009006635 A MX2009006635 A MX 2009006635A MX 2009006635 A MX2009006635 A MX 2009006635A MX 2009006635 A MX2009006635 A MX 2009006635A
Authority
MX
Mexico
Prior art keywords
sup
aminomethyl
hydrogen
cancer
treatment
Prior art date
Application number
MX2009006635A
Other languages
English (en)
Spanish (es)
Inventor
Jason Scott Sawyer
James Robert Henry
Yan Wang
Hong-Yu Li
Harold Burns Brooks
Joyce Z Crich
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2009006635A publication Critical patent/MX2009006635A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
MX2009006635A 2006-12-21 2007-12-11 Compuestos de imidazolidinonil aminopirimidina para el tratamiento de cancer. MX2009006635A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87132206P 2006-12-21 2006-12-21
PCT/US2007/087046 WO2008076705A1 (en) 2006-12-21 2007-12-11 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer

Publications (1)

Publication Number Publication Date
MX2009006635A true MX2009006635A (es) 2009-06-30

Family

ID=39185681

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006635A MX2009006635A (es) 2006-12-21 2007-12-11 Compuestos de imidazolidinonil aminopirimidina para el tratamiento de cancer.

Country Status (21)

Country Link
US (1) US8063212B2 (enExample)
EP (1) EP2125794B1 (enExample)
JP (1) JP2010513553A (enExample)
KR (1) KR101080594B1 (enExample)
CN (1) CN101568539B (enExample)
AT (1) ATE485291T1 (enExample)
AU (1) AU2007334040B2 (enExample)
BR (1) BRPI0720607A2 (enExample)
CA (1) CA2673564A1 (enExample)
CY (1) CY1110950T1 (enExample)
DE (1) DE602007010041D1 (enExample)
DK (1) DK2125794T3 (enExample)
EA (1) EA016178B1 (enExample)
ES (1) ES2351371T3 (enExample)
HR (1) HRP20100641T1 (enExample)
MX (1) MX2009006635A (enExample)
PL (1) PL2125794T3 (enExample)
PT (1) PT2125794E (enExample)
RS (1) RS51526B (enExample)
SI (1) SI2125794T1 (enExample)
WO (1) WO2008076705A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE479680T1 (de) 2006-12-21 2010-09-15 Lilly Co Eli Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs
TW200908981A (en) * 2007-05-16 2009-03-01 Lilly Co Eli Triazolyl aminopyrimidine compounds
CN104781257A (zh) 2012-06-14 2015-07-15 第一三共株式会社 哌啶基吡唑并吡啶衍生物
EP2929883A1 (en) 2014-04-08 2015-10-14 Institut Pasteur Pyrazole derivatives as dihydroorotate dehydrogenase (DHODH) inhibitors
KR102693614B1 (ko) 2022-04-04 2024-08-08 경희대학교 산학협력단 나프탈렌-2-일알킬기가 치환된 이미다졸리움 유도체 및 이를 유효성분으로 포함하는 암 치료용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929726A (en) 1988-02-09 1990-05-29 Georgia State University Foundation, Inc. Novel diazines and their method of preparation
WO2004063192A1 (en) 2003-01-10 2004-07-29 Pharmacopeia Drug Discovery, Inc. Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
CN101115749B (zh) * 2004-12-17 2011-06-22 安姆根有限公司 氨基嘧啶化合物和使用方法
TW200800201A (en) * 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
EP2001480A4 (en) * 2006-03-31 2011-06-15 Abbott Lab Indazole CONNECTIONS
ATE479680T1 (de) 2006-12-21 2010-09-15 Lilly Co Eli Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs
EP2155735A2 (en) 2007-05-16 2010-02-24 Eli Lilly And Company Triazolyl aminopyrimidine compounds
TW200908981A (en) 2007-05-16 2009-03-01 Lilly Co Eli Triazolyl aminopyrimidine compounds

Also Published As

Publication number Publication date
CN101568539B (zh) 2012-04-25
EP2125794A1 (en) 2009-12-02
PT2125794E (pt) 2011-01-10
CY1110950T1 (el) 2015-06-10
BRPI0720607A2 (pt) 2014-04-08
RS51526B (sr) 2011-06-30
US20100081641A1 (en) 2010-04-01
ATE485291T1 (de) 2010-11-15
HRP20100641T1 (hr) 2010-12-31
SI2125794T1 (sl) 2011-02-28
KR20090086111A (ko) 2009-08-10
EP2125794B1 (en) 2010-10-20
DE602007010041D1 (de) 2010-12-02
CN101568539A (zh) 2009-10-28
JP2010513553A (ja) 2010-04-30
EA200970616A1 (ru) 2009-10-30
DK2125794T3 (da) 2011-01-24
AU2007334040A1 (en) 2008-06-26
KR101080594B1 (ko) 2011-11-04
AU2007334040B2 (en) 2012-02-16
ES2351371T3 (es) 2011-02-03
EA016178B1 (ru) 2012-02-28
US8063212B2 (en) 2011-11-22
CA2673564A1 (en) 2008-06-26
PL2125794T3 (pl) 2011-04-29
WO2008076705A1 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
TW200833663A (en) Therapeutic agents
TW200642683A (en) Heterocyclic compound
NZ611764A (en) Therapies for hematologic malignancies
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
PL1678166T3 (pl) Inhibitory kinaz białkowych
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
TNSN07275A1 (fr) Derives de triazole substitues, servant d'antagonistes d'ocytocine
TW200728307A (en) Novel spirochromanone derivatives
MY151295A (en) Pyrimidyl indoline compound
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MX2009003739A (es) Derivados de hidrobenzamida como inhibidores de hsp90.
PL1696905T3 (pl) Zastosowanie podstawionych 2-aminotetralin do zapobiegawczego leczenia choroby parkinsona
MX2010001020A (es) Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas.
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
MX2011013648A (es) Nuevos compuestos, composiciones farmaceuticas y metodos relacionados con ellos.
UA95916C2 (ru) Производные хинолина как антибактериальные средства
MX2010001566A (es) Derivado de aminopirazolamida.
MX2009006635A (es) Compuestos de imidazolidinonil aminopirimidina para el tratamiento de cancer.
MX2007013624A (es) Inhibidores de proteina cinasa.
MY133527A (en) Isoquinoline derivatives
IL195016A0 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
TW200716547A (en) Piperidin-4-yl-amide derivatives
MY139704A (en) Naphthalene derivatives for use as histamine-3-receptor ligands
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
JO2937B1 (en) Tight muscles of the peptide vascular tensioner receptor

Legal Events

Date Code Title Description
FG Grant or registration